Search Results 861-870 of 19830 for Hepatitis b

1. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Hepatitis B carriers are eligible only if antiviral therapy is administered as outlined in the guidelines in the protocol. Hepatitis B carrier is defined as ...

2. A Registry for Participants with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection - Mayo Clinic

   ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus (HCV) study or commercially at selected sites. Once enrolled ...

3. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection - Mayo Clinic

   ... Hepatitis C Infection. Print details. Share; Facebook · Twitter. Overview ... hepatitis C virus study or commercially at selected sites. Once enrolled, the ...

4. A Study to Evaluate Adjuvant Ado-Trastuzumab Emtansine (T-DM1) in HER2 Positive Breast Cancer - Mayo Clinic

   Positive Hepatitis B (Hepatitis B surface antigen and antibody) and/or Hepatitis C (Hepatitis C antibody test) as indicated by serologies conducted ≤3 ...

5. Etanercept (subcutaneous route) - Side effects & dosage - Mayo Clinic

   May make these conditions worse. Cancer, history of or; Diabetes or; Disease of the immune system, history of or; Infections (eg, hepatitis B, bacteria, fungus, ...

6. Clinical Trials - AUTO1 in Relapsed or Refractory B-ALL

   ... B-Cell Acute Lymphoblastic Leukaemia (r/r B-ALL). Participation eligibility ... Active or latent Hepatitis B virus or active Hepatitis C virus. Human ...

7. Helicobacter pylori (H. pylori) infection - Symptoms & causes - Mayo Clinic

   Bittencourt de Brito B, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World Journal of Gastroenterology. 2019; doi ...

8. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   Patients with evidence of hepatitis B virus (HBV) are eligible provided there is minimal hepatic injury and the patient has undetectable HBV on suppressive ...

9. An Expanded Access Study Of Sofosbuvir Combined With Ribavirin And Either With Or Without Pegylated Interferon For Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

   Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

10. Sutimlimab-jome (intravenous route) - Side effects & uses - Mayo Clinic

    Other Medical Problems · Hepatitis B or C or · HIV infection or · Serious infections or · Systemic lupus erythematosus (SLE)—Use with caution. May make these ...